Clinical and Microbiologic Outcomes of Adjunctive Antimicrobial Photodynamic Therapy in the Non-surgical and Surgical Treatment of Teeth With Periodontal Disease

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05252000
Collaborator
(none)
20
1
2
27.8
0.7

Study Details

Study Description

Brief Summary

The purpose of this study is to compare clinical outcomes after mechanical debridement of at sites exhibiting plaque induced inflammation with or without adjunctive Antimicrobial photodynamic therapy (aPDT) and to assess the the microbiologic profile before and after treatment with or without aPDT

Condition or Disease Intervention/Treatment Phase
  • Device: mechanical debridement
  • Device: adjunctive aPDT
  • Device: sham aPDT
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Clinical and Microbiologic Outcomes of Adjunctive Antimicrobial Photodynamic Therapy in the Non-surgical and Surgical Treatment of Teeth With Periodontal Disease
Anticipated Study Start Date :
Mar 7, 2022
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: mechanical debridement and adjunctive aPDT

Device: mechanical debridement
subjects will receive traditional non-surgical mechanical debridement of tooth surfaces with scalers and ultrasonics removing supragingival and subgingival plaque

Device: adjunctive aPDT
Antimicrobial photodynamic therapy will be done at tooth sites by applying a photosensitizing dye methylene blue (0.1mg/ml) with a disposable syringe from the bottom of pocket in a coronal direction. After 3 minutes in situ, the surrounding gingival tissues will be irradiated at six sites around the tooth using a diode laser with a wavelength of 660nm, providing an energy density of 10 J/site, 100mW power, time equal to 100 seconds. After irradiation, the site will be thoroughly rinsed with saline.

Active Comparator: mechanical debridement and sham aPDT

Device: mechanical debridement
subjects will receive traditional non-surgical mechanical debridement of tooth surfaces with scalers and ultrasonics removing supragingival and subgingival plaque

Device: sham aPDT
subjects will receive saline and non-light emitting laser on the tooth

Outcome Measures

Primary Outcome Measures

  1. Change in number of bleeding sites (Bleeding On Probing) [baseline, at the re-evaluation appointment(4 to 6 weeks after baseline), and 3 months after the osseous surgery]

    Bleeding on probing will be evaluated by gently sweeping the periodontal probe just within the gingival sulcus of the tooth and the presence or absence of bleeding will be recorded.

  2. Change in probing depth (Periodontal pocket depth ) [baseline, at the re-evaluation appointment (4 to 6 weeks after baseline), and 3 months after the osseous surgery]

    Periodontal pocket depth is measured from the free gingival margin to the base of the pocket, with a UNC periodontal probe with 1mm measurement units

Secondary Outcome Measures

  1. change in microbiologic profile of plaque [baseline, at the re-evaluation appointment(4 to 6 weeks after baseline), and 3 months after the osseous surgery]

    Plaque sampling will be performed using a curette within the gingival sulcus of the inflamed site. The sample sites will first be isolated by cotton rolls and supragingival and marginal plaque will be removed before subgingival biofilm samples collected using sterile scalers. The collected samples will be immediately placed in separate sterile Eppendorf tubes containing 0.15 ml TE .Samples will be stored at -80 °C until further analysis.

  2. change in microbiologic profile of gingival crevicular fluid(GCF) [baseline, at the re-evaluation appointment(4 to 6 weeks after baseline), and 3 months after the osseous surgery]

    GCF will be collected from the sulcus around the target tooth using paper strips (PerioPaper, Oraflow). With proper isolation using cotton rolls in the buccal and lingual aspects of the study site, the area will be dried for 5 seconds with compressed air. The paper strip will be gently introduced into the mucosal crevice around the tooth for 30 seconds per site in four sites.The strips will then be removed from the crevice, and the volume of fluid collected in each strip measured using a micromoisture metering device (Peritron, Oraflow). After confirming the adequateness of the volume, the paper strips from each tooth will be transferred into labeled tubes and stored at -80 C for later use. For analysis, the paper strips will be analyzed using multiplexed fluorescent bead-based immunoassay.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • One pocket on each side of the mouth (split design)

  • Single rooted tooth

  • Pocket depths measured greater than 4mm with bleeding on probing

  • Horizontal bone loss

  • No furcation involvement

Exclusion Criteria:
  • current heavy smokers (>10 cigarettes/day)

  • have uncontrolled diabetes (HbA1c ≥ 6.5%)

  • other uncontrolled systemic diseases that may comprise healing, such as Vitamin C deficiency, any neutrophil deficiencies, immunodeficiency syndromes, or leukemia

  • taking antibiotics within 3 months before the procedure

  • vertical bone defects that requires surgical regenerative treatment.

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Texas Health Science Center at Houston Houston Texas United States 77030

Sponsors and Collaborators

  • The University of Texas Health Science Center, Houston

Investigators

  • Principal Investigator: Shreena P Bhakta, DDS, The University of Texas Health Science Center, Houston

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shreena Pranav Bhakta, resident, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT05252000
Other Study ID Numbers:
  • HSC-DB-21-0998
First Posted:
Feb 23, 2022
Last Update Posted:
Feb 23, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Shreena Pranav Bhakta, resident, The University of Texas Health Science Center, Houston
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 23, 2022